From: Forensic short tandem repeat markers alteration in cancerous tissues: a scoping review
STR Markers | Percentage of STR alteration rates (%) | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BC | GCC | LC | CRC | GC | |||||||||||||||
pLOH | LOH | MSI | LOH | MSI | pLOH | LOH | Aadd | Anew | pLOH | cLOH | Aadd | Anew | MSI | pLOH | cLOH | Aadd | Anew | MSI | |
D3S1358 | 1.43 | 7.46 | - | 24.00–40.00 | 3.70 | - | - | - | 7.00 | - | - | 1.30 | - | 73.30 | - | - | - | - | 73.30 |
VWA | - | 8.33 | - | 5.00 | 3.70 | - | - | - | 4.00 | 3.70–11.70 | 14.63 | - | 6.91 | 12.20–48.00 | - | 14.63 | - | 6.91 | 1.23–12.20 |
FGA | - | 5.97–27.00 | 2.00 | - | - | - | - | - | 5.00 | 8.60–10.40 | 1.30–24.03 | 5.69–6.59 | - | 2.47–12.20 | 1.43 | 19.33–21.95 | 4.86 | - | 12.20 |
TH01 | - | 8.33–25.00 | - | 20.00–23.00 | - | - | - | - | 4.00 | - | - | - | - | - | - | - | - | - | - |
TPOX | - | - | - | - | - | - | - | 2.00 | 4.00 | - | - | - | - | - | - | - | - | - | - |
CSF1PO | - | - | - | - | - | - | - | - | - | - | 0.43–23.26 | - | - | - | - | 18.47–21.95 | - | - | - |
D5S818 | - | - | - | - | - | - | 9.00–20.00 | 4.00 | - | 12.90 | 24.03 | - | - | - | - | - | - | - | - |
D13S317 | - | 11.11–16.00 | - | - | - | 4.00 | 36.00 | - | - | 3.00–12.90 | 14.63 | - | - | 12.20 | - | 14.63 | - | - | 12.20 |
D7S820 | - | - | - | - | - | - | - | 2.00 | - | - | - | - | 2.60 | - | - | - | - | - | - |
D8S1179 | - | 11.11 | - | 5.00 | - | - | - | - | - | - | - | - | - | 0.09–80.00 | 2.86 | - | - | - | 17.00–80.00 |
D21S11 | - | 24.00 | - | - | 3.70 | - | 20.83 | - | - | - | - | - | - | 0.09–4.60 | - | - | - | - | 1.23–12.20 |
D18S51 | - | 27.00 | 1.00 | 30.00 | - | - | - | 4.00 | - | 7.41–24.70 | 0.60–43.4 | 5.67 | 0.81 | 0.17–86.70 | 1.43 | 21.85–26.83 | 5.67 | 0.81 | 14.60–86.67 |
D16S539 | 1.23–1.43 | 11.11 | - | 5.00 | - | - | - | - | 4.00 | - | - | - | - | - | 1.43 | - | - | - | - |
D2S1338 | 1.43 | - | - | - | - | - | - | 2.00 | - | - | - | - | - | - | - | - | - | - | - |